Background illustration for clinical trials search

Paid Clinical Trials Phoenix

Discover 1,266 paid clinical trials in Phoenix, Arizona. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)

for
Excessive Sleepiness, Shift-work Disorder
Location: Chandler AZ, Henderson NV, Santa Ana CA, Anaheim CA,
Sponsor: Axsome Therapeutics, Inc.

Sex: All

Age: 18 - 65

Code: NCT06568367

Phase3, Recruiting

52-week Open Label Safety-Tolerability Study

for
Schizophrenia
Location: Chandler AZ, Las Vegas NV, San Diego CA, Anaheim CA,
Sponsor: LB Pharmaceuticals Inc.

Sex: All

Age: 18 - 65

Code: NCT07369154

Phase3, Recruiting

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

for
Non-small Cell Lung Cancer (NSCLC)
Location: Chandler AZ, Gilbert AZ, Goodyear AZ, San Diego CA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07291037

Phase3, Recruiting

Prospective Multi-Center Trial for FemBloc Permanent Birth Control

for
Contraception
Location: Chandler AZ, Salt Lake City UT, Palo Alto CA,
Sponsor: Femasys Inc.

Sex: Female

Age: 21 - 50

Code: NCT05977751

Recruiting

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

for
Non-alcoholic Fatty Liver Disease
Location: Chandler AZ, Tucson AZ, Las Vegas NV, San Diego CA,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 70+

Code: NCT07221227

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis

for
Liver Fibrosis, Hepatic Cirrhosis
Location: Chandler AZ, Tucson AZ, Las Vegas NV, Yukon OK,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07610837

Phase2, Recruiting

A Phase I Study to Investigate the Effect of Hepatic Impairment of AZD9550 and AZD6234

for
Hepatic Impairment
Location: Chandler AZ, Rialto CA, San Antonio TX, Miami Lakes FL
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT07546760

Phase1, Recruiting

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease

for
Alzheimer's Disease
Location: Chandler AZ, Las Vegas NV, Garden Grove CA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 55 - 70+

Code: NCT07011745

Phase3, Recruiting

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma

for
Asthma
Location: Chandler AZ, Henderson NV, Newport Beach CA,
Sponsor: Pfizer

Sex: All

Age: 18 - 70

Code: NCT06977581

Phase2, Recruiting

An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures

for
Focal Onset Seizure, Primary Generalized Epilepsy
Location: Phoenix AZ, Round Rock TX, Seabrook TX, Chesterfield MO,
Sponsor: Praxis Precision Medicines

Sex: All

Age: 18 - 70+

Code: NCT06908356

Phase2, Recruiting

A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer

for
HER2-positive Gastric Cancer,
Location: Phoenix AZ, La Jolla CA, Upland CA, Duarte CA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06764875

Phase3, Recruiting

AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)

for
Relapsed/Refractory Multiple Myeloma
Location: Phoenix AZ, La Jolla CA, Los Angeles CA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT05850234

Phase1, Phase2, Recruiting

A Platform Study in Non-Small Cell Lung Cancer (NSCLC)

for
Advanced or Metastatic Non-small Cell Lung Cancer
Location: Phoenix AZ, Santa Rosa CA, Tyler TX, Rochester MN,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06996782

Phase1, Phase2, Recruiting

A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)

for
Biliary Tract Cancer
Location: Phoenix AZ, Tucson AZ, Orange CA, Duarte CA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07221253

Phase3, Recruiting

Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

for
Metastatic Clear Cell Renal Cell Carcinoma,
Location: Phoenix AZ, Gilbert AZ, Goodyear AZ, San Diego CA,
Sponsor: Arcus Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT07011719

Phase3, Recruiting

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

for
Prostate Cancer
Location: Phoenix AZ, San Diego CA, La Jolla CA, Los Angeles CA,
Sponsor: AstraZeneca

Sex: Male

Age: 18+

Code: NCT06952803

Phase3, Recruiting

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

for
Hepatocellular Carcinoma
Location: Phoenix AZ, Tucson AZ, Los Angeles CA, Amarillo TX,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06921785

Phase3, Recruiting

Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation

for
Delayed Graft Function, DGF, Kidney Transplant
Location: Phoenix AZ, Los Angeles CA, Stanford CA,
Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT06830798

Phase3, Recruiting

Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC

for
Hepatocellular Carcinoma (HCC)
Location: Phoenix AZ, Tucson AZ, Orange CA, Houston TX, Omaha NE,
Sponsor: RayzeBio, Inc.

Sex: All

Age: 18+

Code: NCT06726161

Phase1, Phase2, Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC

for
Non-squamous Non-small Cell Lung Cancer
Location: Phoenix AZ, San Diego CA, Redlands CA, Loma Linda CA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06627647

Phase3, Recruiting

With several prominent research institutions and a robust healthcare network, Phoenix stands out as a significant hub for clinical trials. The city hosts leading medical centers such as the Mayo Clinic’s Scottsdale campus, the Translational Genomics Research Institute (TGen), and the Arizona State University (ASU) Biomedical Engineering department. These institutions are at the forefront of advancing clinical research and innovation. The diverse population of Phoenix provides a broad participant base too, enhancing the accuracy and relevance of clinical studies.

Why choose Phoenix for clinical trials?

Phoenix offers distinctive advantages for those volunteering in clinical trials. The city's diverse and growing population provides a rich pool of participants, which enhances the accuracy and applicability of research outcomes.

Choosing to participate in a clinical trial in Phoenix allows individuals to contribute to critical medical advancements while benefiting from a supportive and well-established clinical research environment. The city's combination of a diverse participant base and cutting-edge research facilities makes it an ideal location for advancing medical science and improving healthcare outcomes.

Common conditions studied in Phoenix

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Phoenix